Global and China Acromegaly Market 2021 by Company, Type and Application, Forecast to 2026
Global and China Acromegaly Market 2021 by Company, Type and Application, Forecast to 2026
The Acromegaly Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Market Overview
The global Acromegaly market size is expected to gain market growth in the forecast period of 2021 to 2026, with a CAGR of xx% in the forecast period of 2021 to 2026 and will expected to reach USD xx million by 2026, from USD xx million in 2020.
The Acromegaly market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Acromegaly market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Acromegaly market has been segmented into Somatostatin Analogues, Dopamine Agonists, Growth Hormone Receptor Antagonists, Other, etc.
Breakdown by Application, Acromegaly has been segmented into Hospitals, Clinics, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acromegaly market presented in the report. This section sheds light on the sales growth of different regional and country-level Acromegaly markets. For the historical and forecast period 2016 to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acromegaly market.
For China, this report analyses the China market by players, Type and Application, For the period 2016-2026.
Competitive Landscape and Acromegaly Market Share Analysis
Acromegaly competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Acromegaly revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2016-2021, this study provides the Acromegaly revenue and market share for each player covered in this report.
The major players covered in Acromegaly are: Novartis, Strongbridge Biopharma, Crinetics Pharmaceuticals, Aegis Therapeutics, Silence Therapeutics, Chiasma, Foresee Pharmaceuticals, Peptron, Daewoong Pharmaceutical, Amryt Pharma, Glide Pharmaceutical, Ionis Pharmaceuticals, Ipsen, etc. Among other players domestic and global, Acromegaly market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Novartis
Strongbridge Biopharma
Crinetics Pharmaceuticals
Aegis Therapeutics
Silence Therapeutics
Chiasma
Foresee Pharmaceuticals
Peptron
Daewoong Pharmaceutical
Amryt Pharma
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Market segment by Application, can be divided into
Hospitals
Clinics
1 Market Overview
1.1 Product Overview and Scope of Acromegaly
1.2 Classification of Acromegaly by Type
1.2.1 Overview: Global Acromegaly Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Acromegaly Revenue Market Share by Type
1.2.3 Somatostatin Analogues
1.2.4 Dopamine Agonists
1.2.5 Growth Hormone Receptor Antagonists
1.2.6 Other
1.3 Global Acromegaly Market by Application
1.3.1 Overview: Global Acromegaly Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Acromegaly Market Size and Forecast (2016-2026)
1.5 Global Acromegaly Market Size by Regions: 2019 Versus 2021 Versus 2026
1.6 Global Acromegaly Market Size by Regions (2016-2021)
1.7 Global Acromegaly Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Acromegaly Status and Prospect (2016-2026)
1.7.2 Europe Acromegaly Status and Prospect (2016-2026)
1.7.3 Asia Acromegaly Status and Prospect (2016-2026)
1.7.4 South America Acromegaly Status and Prospect (2016-2026)
1.7.5 Middle East & Africa Acromegaly Status and Prospect (2016-2026)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.2 Strongbridge Biopharma
2.2.1 Strongbridge Biopharma Details
2.2.2 Strongbridge Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Strongbridge Biopharma SWOT Analysis
2.2.4 Strongbridge Biopharma Product and Services
2.2.5 Strongbridge Biopharma Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.3 Crinetics Pharmaceuticals
2.3.1 Crinetics Pharmaceuticals Details
2.3.2 Crinetics Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Crinetics Pharmaceuticals SWOT Analysis
2.3.4 Crinetics Pharmaceuticals Product and Services
2.3.5 Crinetics Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.4 Aegis Therapeutics
2.4.1 Aegis Therapeutics Details
2.4.2 Aegis Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aegis Therapeutics SWOT Analysis
2.4.4 Aegis Therapeutics Product and Services
2.4.5 Aegis Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.5 Silence Therapeutics
2.5.1 Silence Therapeutics Details
2.5.2 Silence Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Silence Therapeutics SWOT Analysis
2.5.4 Silence Therapeutics Product and Services
2.5.5 Silence Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.6 Chiasma
2.6.1 Chiasma Details
2.6.2 Chiasma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Chiasma SWOT Analysis
2.6.4 Chiasma Product and Services
2.6.5 Chiasma Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.7 Foresee Pharmaceuticals
2.7.1 Foresee Pharmaceuticals Details
2.7.2 Foresee Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Foresee Pharmaceuticals SWOT Analysis
2.7.4 Foresee Pharmaceuticals Product and Services
2.7.5 Foresee Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.8 Peptron
2.8.1 Peptron Details
2.8.2 Peptron Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Peptron SWOT Analysis
2.8.4 Peptron Product and Services
2.8.5 Peptron Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.9 Daewoong Pharmaceutical
2.9.1 Daewoong Pharmaceutical Details
2.9.2 Daewoong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Daewoong Pharmaceutical SWOT Analysis
2.9.4 Daewoong Pharmaceutical Product and Services
2.9.5 Daewoong Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.10 Amryt Pharma
2.10.1 Amryt Pharma Details
2.10.2 Amryt Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amryt Pharma SWOT Analysis
2.10.4 Amryt Pharma Product and Services
2.10.5 Amryt Pharma Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.11 Glide Pharmaceutical
2.11.1 Glide Pharmaceutical Details
2.11.2 Glide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Glide Pharmaceutical SWOT Analysis
2.11.4 Glide Pharmaceutical Product and Services
2.11.5 Glide Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.12 Ionis Pharmaceuticals
2.12.1 Ionis Pharmaceuticals Details
2.12.2 Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ionis Pharmaceuticals SWOT Analysis
2.12.4 Ionis Pharmaceuticals Product and Services
2.12.5 Ionis Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
2.13 Ipsen
2.13.1 Ipsen Details
2.13.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ipsen SWOT Analysis
2.13.4 Ipsen Product and Services
2.13.5 Ipsen Acromegaly Revenue, Gross Margin and Market Share (2019-2020)
3 Market Competition, by Players
3.1 Global Acromegaly Market Size by Players (2016-2021)
3.2 China Acromegaly Market Size by Players (2016-2021)
3.3 Market Concentration Rate
3.3.1 Top 5 Acromegaly Players Market Share
3.3.2 Top 10 Acromegaly Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Acromegaly Market Size by Countries (2016-2021)
4.2 North America Acromegaly Market Size and Forecast by Countries (2015-2026)
4.3 United States Acromegaly Market Size and Forecast (2016-2026)
4.4 Canada Acromegaly Market Size and Forecast (2016-2026)
4.5 Mexico Acromegaly Market Size and Forecast (2016-2026)
5 Europe Market Size and Forecast by Countries
5.1 Europe Acromegaly Market Size by Countries (2016-2021)
5.2 Europe Acromegaly Market Size and Forecast by Countries (2015-2026)
5.3 Germany Acromegaly Market Size and Forecast (2016-2026)
5.4 France Acromegaly Market Size and Forecast (2016-2026)
5.5 UK Acromegaly Market Size and Forecast (2016-2026)
5.6 Russia Acromegaly Market Size and Forecast (2016-2026)
5.7 Italy Acromegaly Market Size and Forecast (2016-2026)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Acromegaly Market Size by Regions (2016-2021)
6.2 Asia-Pacific Acromegaly Market Size and Forecast by Regions (2015-2026)
6.3 China Acromegaly Market Size and Forecast (2016-2026)
6.4 Japan Acromegaly Market Size and Forecast (2016-2026)
6.5 Korea Acromegaly Market Size and Forecast (2016-2026)
6.6 India Acromegaly Market Size and Forecast (2016-2026)
6.7 Southeast Asia Acromegaly Market Size and Forecast (2016-2026)
7 South America Market Size and Forecast by Countries
7.1 South America Acromegaly Market Size by Countries (2016-2021)
7.2 South America Acromegaly Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Acromegaly Market Size and Forecast (2016-2026)
7.4 Argentina Acromegaly Market Size and Forecast (2016-2026)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Acromegaly Revenue by Regions (2016-2021)
8.2 Middle East & Africa Acromegaly Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Acromegaly Market Size and Forecast (2016-2026)
8.4 UAE Acromegaly Market Size and Forecast (2016-2026)
8.5 Egypt Acromegaly Market Size and Forecast (2016-2026)
8.6 South Africa Acromegaly Market Size and Forecast (2016-2026)
9 Market Size Segment by Type
9.1 Global Acromegaly Market Size and Forecast by Type (2016-2026)
9.1.1 Global Acromegaly Market Size by Type (2016-2021)
9.1.2 Global Acromegaly Market Size Forecast by Type (2020-2025)
9.2 China Acromegaly Market Size and Forecast by Type (2016-2026)
9.2.1 China Acromegaly Market Size by Type (2016-2021)
9.2.2 China Acromegaly Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Acromegaly Market Size and Forecast by Application (2016-2026)
10.1.1 Global Acromegaly Market Size by Application (2016-2021)
10.1.2 Global Acromegaly Market Size Forecast by Application (2020-2025)
10.2 China Acromegaly Market Size and Forecast by Application (2016-2026)
10.2.1 China Acromegaly Market Size by Application (2016-2021)
10.2.2 China Acromegaly Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
Research Methodology:
Acromegaly Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|